1. Home
  2. GRNQ vs ONCO Comparison

GRNQ vs ONCO Comparison

Compare GRNQ & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

N/A

Current Price

$10.35

Market Cap

23.6M

Sector

Technology

ML Signal

N/A

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$0.66

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRNQ
ONCO
Founded
2013
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.6M
3.0M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
GRNQ
ONCO
Price
$10.35
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
123.2K
417.5K
Earning Date
05-13-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
$3,673,997.00
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.55
N/A
52 Week Low
$1.04
$0.09
52 Week High
$22.70
$6.73

Technical Indicators

Market Signals
Indicator
GRNQ
ONCO
Relative Strength Index (RSI) 46.91 42.18
Support Level $1.51 $0.61
Resistance Level $14.40 $1.01
Average True Range (ATR) 2.65 0.09
MACD -0.79 0.00
Stochastic Oscillator 4.34 12.78

Price Performance

Historical Comparison
GRNQ
ONCO

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China, and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust, & wealth management. Its segments include the Service business engaged in the provision of corporate advisory & business solution services; the Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong & Malaysia; & the Digital business segment engaged in the provision of digital platform & trading of digital assets.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: